ATA Guidelines Tools

Anaplastic Thyroid Cancer

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/555197

Contents of this Issue

Navigation

Page 3 of 13

2 Diagnosis Table 2. Immunohistochemical Markers Useful for the Diagnosis of Anaplastic Thyroid Cancer Immunohistochemical marker DTC MTC ATC SCC Lymphoma Pankeratin (AE1/AE3) + + +/– + – a High molecular weight keratins + (PTC) – (FTC) – –/+ + – TTF –1 + +/– –/+ – – PAX8 + +/– +/– – +/– b yroglobulin + – – – – Synaptophysin – + – – – Chromogranin – + – – – Calcitonin – + – – – CEA – + – – – P53 – (rare +) – + +/– + / – E–cadherin + – + – B–catenin membranous nuclear or – + / – (nuclear) CD45 + +, positive; – , negative; + / – , usually positive, oen negative; – / +, usually negative, may be positive. a Plasmablastic lymphoma, anaplastic large cell lymphoma, and very rarely some diffuse large B cell lymphomas can express cytokeratin that is detected by AE1/AE3 cytokeratin monoclonal antibodies. b PAX8 was detected by immunohistochemistry in normal B cells, but was not studied in lymphoma. It is very likely that various lymphomas express PAX8. Table 3. Residual Tumor (R) Classification R0 = No residual tumor R1 = Microscopic residual tumor R2 = Macroscopic residual tumor RX = Presence of residual tumor cannot be assessed Source: Edge et al. 2010 AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual, 7th ed. Springer-Verlag, New York.

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Anaplastic Thyroid Cancer